2. Does amlexanox treatment improve measures of NAFLD in obese patients? All participants in the clinical proof-of-concept study outlined in the aim above will be studied for the degree of steatosis in the liver with the use of MRI and MR spectroscopy at baseline and at 3 months of the study.